Standard Biotools Inc. · Brief

Next report

2 days

Nov 3 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

0 of 8≥ implied

May 6 '25±51.9%▼−3.77%×0.07

Aug 11 '25±19.6%▲+2.34%×0.12

Nov 4 '25±71.1%▼−4.20%×0.06

Jan 8 '26±38.3%▲+20.31%×0.53

Jan 30 '26±18.1%▼−0.71%×0.04

Feb 24 '26±22.9%▲+1.74%×0.08

Q1 FY26±44.5%▼−1.07%×0.02

Q2 FY26±41.1%▲+2.04%×0.05

quarterimplied−75%0+75%realized×

Q2 FY26±41.1%▲+2.04%×0.05

Q1 FY26±44.5%▼−1.07%×0.02

Feb '26±22.9%▲+1.74%×0.08

Jan '26±18.1%▼−0.71%×0.04

Jan '26±38.3%▲+20.31%×0.53

Nov '25±71.1%▼−4.20%×0.06

2 older reports

Aug '25±19.6%▲+2.34%×0.12

May '25±51.9%▼−3.77%×0.07

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 3 report · est.

Bull1

141managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

10managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

9 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

LAB report session

No linked exposure.

Oct 20impliedImplied move: ±38.1% into Nov 3 earnings (Oct 20 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.